The plant cell growth company
Plant-Based Technology is the future, and our sustainable bioFarming technology enables us to produce specific types of plant cells without having to grow the entire plant. We have a robust product pipeline that will deliver finger-print consistent, higher-quality, and lower-cost ingredients for pharmaceutical, nutraceutical, and health supplement products.
BioHarvest Sciences has a clear Path to Commercialization:
- Targeting 1H 2022 for first sales of cannabis product
- July 15, 2021 – Released inaugural Environmental, Sustainability and Governance (ESG) Report
- May 2021 – Successful U.S. Vinia ecommerce launch
- Q3 2021 – 20 Ton Production facility for Vinia to be online (Currently at 2 Tons per year capacity)
- March 2021 -Unveiled Upcoming Olive based Nutraceutical for 2022
- February 9, 2021 – Announced ability to optimize Trichome growth across multiple cannabis strains
- December 2020 – First significant B2B US sale announced with Designs For Health and Batory Foods
- Q4 2020 – Vinia Israel e-commerce launch exceeds projections
- September 2020 – US Distribution agreement with Batory Foods for up to $18 Million of Vinia over 7 years
- Patented technology
- Proven Management team on both Product Development and Commercialization
- Low Cap Ex alternative to traditional agriculture that will allow scalable production of ingredients such as hemp based CBD, grape, olive, and pomegranate products
Subscribe
Recent News Releases
Investor Inquiries
-
Ilan Sobel
CEO-
E-MAIL
Ilan@bioharvest.com
-
-
David Ryan
VP Investor Relations-
E-MAIL
dave@bioharvest.com -
PHONE
CA - 1-604-622-1186
-
-
Justin Meiklem
Investor Relations-
E-MAIL
justin@bioharvest.com -
PHONE
CA - 778-686-3855
-
